RxDoctor Payments Data

Tyler Sandow

Vascular & Interventional Radiology · New Orleans, LANPI 1699033225

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $393,569 of the $484,972 with a category attached, or 81.2%. Boston Scientific accounts for 91.6% of it on its own, with 25 other manufacturers making up the rest. Among vascular & interventional radiology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$484,972in general payments, 2019–2025

Across 590 payments — averaging $821.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$444K
  • Sirtex Medical Inc$14K
  • Trisalus Life Sciences, Inc.$14K
  • Astrazeneca UK Limited$2K
  • Terumo Medical Corporation$1K
  • Biocompatibles, Inc.$1K
  • plus $7K from 20 others
$19,568in research payments, 2019–2025

Across 3 payments — averaging $6522.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bard Peripheral Vascular, Inc.$20K

What the payments were for

  • Consulting fees$35,7937%
  • Speaking & faculty fees$393,56981%
  • Grants$8000%
  • Travel & lodging$30,4006%
  • Food & beverage$24,3115%
  • Education$1000%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$484,972 in reported general payments places this provider in the 95th percentile of 42 vascular & interventional radiology providers in Louisiana.

See all vascular & interventional radiology providers in Louisiana

Medicare billing

Part B allowed, 2024
$107,748
Medicare patients
173
Services billed
1,231

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$88
Oxycodone Hcl17$51

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →